B.GRIMM Pharma had the honor of hosting Dr. Surachoke Tangwiwat, Secretary-General of the Food and Drug Administration (FDA), along with delegates from FDA Office, Ministry of Public Health who visited our Unison Factory.
The delegation visited our quality assurance and R&D operations and expressed their appreciation for our commitment to World-Class Standards, advanced technologies, disease prevention, and innovative treatments addressing the evolving health needs of society.
